Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

UK ROPE Register Study (UK ROPE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02434575
Recruitment Status : Completed
First Posted : May 5, 2015
Last Update Posted : February 7, 2020
Sponsor:
Collaborators:
British Society of Interventional Radiologists
British Association of Urological Surgeons
National Instutite of Health and Care Excellence
Information provided by (Responsible Party):
Dr Grace Carolan-Rees, Cardiff and Vale University Health Board

Brief Summary:

This registry study enables us to collect data on the treatment of LUTS using prostate artery embolisation (PAE), and other surgical methods to answer the following questions posed by NICE in 2013:

  • Is PAE a safe and effective treatment option for LUTS caused by prostate enlargement?
  • How does PAE compare with conventional surgical treatments? This will primarily be a surgical procedure called transurethral resection of the prostate (TURP) (see below).
  • Which patients would most benefit from PAE over the other treatment options?

Condition or disease
Lower Urinary Tract Symptoms

Detailed Description:

This is a study protocol for the UK ROPE Register for Lower Urinary Tract Symptoms (LUTS). This register enables us to collect data on the treatment of LUTS using prostate artery embolisation (PAE), and other surgical methods to answer the following questions posed by NICE in 2013:

  • Is PAE a safe and effective treatment option for LUTS caused by prostate enlargement?
  • How does PAE compare with conventional surgical treatments? This will primarily be a surgical procedure called transurethral resection of the prostate (TURP) (see below).
  • Which patients would most benefit from PAE over the other treatment options? This study involves populating the UK ROPE Register with data from patients who have undergone prostate artery embolisation (PAE) and the current standard treatment in the UK, transurethral resection of the prostate (TURP). All consecutive patients receiving PAE in UK sites taking part in this study over the course of 12 months (from the date that the first patient is enrolled) will be invited to join the UK ROPE register. At least 150 PAE patients will be enrolled into this study, and a comparable number of TURP patients (at least 150 patients also) from a maximum of 18 sites in the UK. It is anticipated that each site will enrol between 10 and 30 PAE patients in 12 months. Enrolment will only continue past 12 months until 150 PAE patients have been added to the register.

NICE has suggested keeping a registry or database of patients who have undergone this procedure in the UK. so that we can find out more about how safe and effective it is for patients and how it compares to the other established treatments available such as surgery. The UK ROPE Register will be owned and hosted by the British Society of Interventional Radiologists (BSIR) and the British Association of Urological Surgeons (BAUS). The register will be built by Dendrite, a commercial company that specialise in making medical registers and databases. Cedar, a consortium of Cardiff & Vale UHB and Cardiff University and an External Assessment Centre (EAC) to NICE, was commissioned to facilitate the registry research. Cedar's role is to work with the steering group (consisting of BSIR, BAUS, and NICE representatives) to help build the ROPE Register and ensure that the right data points are collected to answer research questions for NICE. Cedar will also perform the data analysis from the ROPE Register and will publish the results in a peer-reviewed scientific journal.

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 318 participants
Observational Model: Case-Control
Time Perspective: Prospective
Target Follow-Up Duration: 12 Months
Official Title: ROPE Registry Project to Determine the Safety and Efficacy of Prostate Artery Embolisation (PAE) for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Enlargement (LUTS BPE)
Study Start Date : July 2014
Actual Primary Completion Date : December 2016
Actual Study Completion Date : December 31, 2016

Resource links provided by the National Library of Medicine


Group/Cohort
PAE
Men with LUTS BPE who have opted for PAE at a participating site, and have consented to take part in the UK ROPE Register Study.
TURP
Men with LUTS BPE who have consented to TURP at a participating site, and have consented to the UK ROPE Register Study.
Other
Men with LUTS BPE who have had an Open Prostatectomy or laser surgery at a participating site, and have consented to the UK ROPE Study.



Primary Outcome Measures :
  1. IPSS change for PAE patients, from baseline 12 months post procedure [ Time Frame: 12 months ]
    Comparison of IPSS questionnaire score at baseline at 12 months post-PAE procedure


Secondary Outcome Measures :
  1. IPSS comparison of PAE with TURP, 12 months post-procedure [ Time Frame: 12 Months ]
    Comparison of IPSS score changes between PAE and TURP cases, 12 months post-procedure. Non inferiority study.

  2. Safety of PAE procedure - Number of patients with adverse events up to 12 months post-procedure [ Time Frame: 12 months ]
    Any anticipated complications of PAE should be recorded on the ROPE Register up to 12 months post-procedure. These include: Local dissection, non-target embolisation, groin haematoma, sepsis, transfusion, TUR syndrome, bladder wall injury, antibiotics needed post-PAE (implying infection), and catheterisation. Patient-reported complications include pain, haematuria, haematospermia, retrograde ejaculation, catheterisation, and hospital re-admission.

  3. IPSS comparison of other treatments (HoLEP, Open prostatectomy) to PAE, 12 months post-procedure [ Time Frame: 12 months ]
    Descriptive statistics for comparison of PAE with other treatments (HoLEP, Open prostatectomy) using IPSS.

  4. IIEF comparison of TURP, HoLEP and Open prostatectomy to PAE, 12 months post-procedure. [ Time Frame: 12 months ]
    Descriptive statistics for comparison of PAE with other treatments (Open Prostatectomy or laser surgery) using IIEF.

  5. Prostate volume comparison of TURP, HoLEP and Open prostatectomy to PAE, 12 months post-procedure. [ Time Frame: 12 months ]
    Descriptive statistics for comparison of PAE with other treatments (TURP, Open Prostatectomy or HoLEP) using prostate volume.

  6. Urinary flow study comparison of TURP, HoLEP and Open prostatectomy to PAE, 12 months post-procedure. [ Time Frame: 12 months ]
    Descriptive statistics for comparison of PAE with other treatments (TURP, Open Prostatectomy or HoLEP) using urinary flow studies.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Men with LUTS BPE who have consented to PAE, TURP, Open prostatectomy or laser surgery at a participating UK site.
Criteria

Inclusion Criteria:

  • Men with LUTS who have consented for PAE, TURP, open prostatectomy or laser surgery at a participating site
  • Able to read, write and understand English
  • Capable of giving informed written consent

Exclusion Criteria:

  • Not able to read, write or understand English
  • Not able/willing to provide informed written consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02434575


Locations
Show Show 17 study locations
Sponsors and Collaborators
Cardiff and Vale University Health Board
British Society of Interventional Radiologists
British Association of Urological Surgeons
National Instutite of Health and Care Excellence
Additional Information:
Publications of Results:
Layout table for additonal information
Responsible Party: Dr Grace Carolan-Rees, Cedar Director, Cardiff and Vale University Health Board
ClinicalTrials.gov Identifier: NCT02434575    
Other Study ID Numbers: 14/NE/0128
First Posted: May 5, 2015    Key Record Dates
Last Update Posted: February 7, 2020
Last Verified: February 2020
Keywords provided by Dr Grace Carolan-Rees, Cardiff and Vale University Health Board:
Lower Urinary Tract Symptoms
Prostatic artery embolisation
Transurethral resection of the prostate
Benign prostatic hyperplasia
Benign prostatic enlargement
Additional relevant MeSH terms:
Layout table for MeSH terms
Lower Urinary Tract Symptoms
Urological Manifestations
Signs and Symptoms